These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17172917)

  • 1. Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs.
    Flach AJ
    Cornea; 2006 Dec; 25(10):1265-6. PubMed ID: 17172917
    [No Abstract]   [Full Text] [Related]  

  • 2. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug.
    Rho DS
    Cornea; 2006 Dec; 25(10):1266-7; author reply 1267-8. PubMed ID: 17172918
    [No Abstract]   [Full Text] [Related]  

  • 3. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug.
    Asai T; Nakagami T; Mochizuki M; Hata N; Tsuchiya T; Hotta Y
    Cornea; 2006 Feb; 25(2):224-7. PubMed ID: 16371788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.
    Lin JC; Rapuano CJ; Laibson PR; Eagle RC; Cohen EJ
    Arch Ophthalmol; 2000 Aug; 118(8):1129-32. PubMed ID: 10922213
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute corneal melt associated with topical bromfenac use.
    Prasher P
    Eye Contact Lens; 2012 Jul; 38(4):260-2. PubMed ID: 22169877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of bromfenac for the treatment of corneal ulcer pain.
    Schechter BA; Trattler W
    Adv Ther; 2010 Oct; 27(10):756-61. PubMed ID: 20845001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
    Donnenfeld ED; Donnenfeld A
    Int Ophthalmol Clin; 2006; 46(4):21-40. PubMed ID: 17060789
    [No Abstract]   [Full Text] [Related]  

  • 9. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.
    Flach AJ
    Trans Am Ophthalmol Soc; 2001; 99():205-10; discussion 210-2. PubMed ID: 11797308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromfenac (Duract)-associated hepatic failure requiring liver transplantation.
    Hunter EB; Johnston PE; Tanner G; Pinson CW; Awad JA
    Am J Gastroenterol; 1999 Aug; 94(8):2299-301. PubMed ID: 10445569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment.
    Flach A
    Ophthalmology; 2000 Jul; 107(7):1224-6. PubMed ID: 10889089
    [No Abstract]   [Full Text] [Related]  

  • 12. Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use.
    Isawi H; Dhaliwal DK
    J Cataract Refract Surg; 2007 Sep; 33(9):1644-6. PubMed ID: 17720085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
    Jones J; Francis P
    Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One case of corneal melting after instillation of bromfenac 0.09%].
    Troumani Y; Beral L; Glatre F; Finke E; David T
    J Fr Ophtalmol; 2014 Oct; 37(8):e125-7. PubMed ID: 24838029
    [No Abstract]   [Full Text] [Related]  

  • 16. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
    Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
    Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional factors linking corneal melting to topical nonsteroidal anti-inflammatory drugs.
    Flach A
    Arch Ophthalmol; 2001 Jul; 119(7):1085. PubMed ID: 11448339
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
    Uchio E; Itoh Y; Kadonosono K
    Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal melting associated with topical diclofenac use after laser-assisted subepithelial keratectomy.
    Zanini M; Savini G; Barboni P
    J Cataract Refract Surg; 2006 Sep; 32(9):1570-2. PubMed ID: 16931276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration and dosing of ketorolac versus bromfenac.
    Gayton J
    J Cataract Refract Surg; 2009 Jul; 35(7):1319; author reply 1320. PubMed ID: 19545832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.